NRx Pharmaceuticals
Medicines for Life-threatening CNS Diseases
StartupNRx Pharmaceuticals is a Haifa-based startup in the Health Tech & Life Sciences sector, established in 2014. Medicines for Life-threatening CNS Diseases. The company has raised a total of $176.18M across 7 funding rounds, currently at the Public stage. NRx Pharmaceuticals was founded by Daniel C. Javitt, Prof., M.D., Ph.D and Jonathan C. Javitt, M.D., M.P.H., Ph.D. Key investors include Undisclosed Investor(s). The company has 11-50 employees. Core technologies: Biologicals, Molecules.
With $176.18M in total funding, NRx Pharmaceuticals is a Public-stage company operating in Health Tech & Life Sciences. The company follows a B2B business model. Product stage: Clinical Trial. The company holds 1 patent.
- StagePublic
- ProductClinical Trial
- ModelB2B
- Employees11-50
- HQHaifa
- DistrictNorth District
- Last Round$16M
- Undisclosed Investor(s)
Daniel C. Javitt, Prof., M.D., Ph.DChairman & Co-FounderJonathan C. Javitt, M.D., M.P.H., Ph.DCo-Founder
244 articles covered by sources including finance.yahoo.com,
newsdirect.com,
www.prnewswire.com,
www.globenewswire.com,
www.ynetnews.com.
What does NRx Pharmaceuticals do?
NeuroRX is a specialized CNS biopharma company, resolutely focused on meeting very high unmet medical needs for those with severe bipolar depression with suicidality and post-traumatic stress disorder (PTSD). The company growing pipeline is powered by its proprietary, dual-targeted mechanism of action, which safely modulates the NMDA and 5HT2A receptors. Its mission is to bring hope to people with life-threatening diseases through breakthrough science.
How much funding has NRx Pharmaceuticals raised?
NRx Pharmaceuticals has raised $176.18M in total funding across 7 rounds. The company is currently at the Public stage. Key investors include Undisclosed Investor(s).
Who founded NRx Pharmaceuticals?
NRx Pharmaceuticals was founded in 2014 by Daniel C. Javitt, Prof., M.D., Ph.D (Chairman & Co-Founder), Jonathan C. Javitt, M.D., M.P.H., Ph.D (Co-Founder).
What sector is NRx Pharmaceuticals in?
NRx Pharmaceuticals operates in Health Tech & Life Sciences, Pharma & Medical Biotechnology, Drugs Discovery & Development, with core technologies in Biologicals, Molecules. Target customers: Healthcare & Life Sciences, Healthcare, Patients, Providers.
Where is NRx Pharmaceuticals located?
NRx Pharmaceuticals is based in Andrei Sakharov St 9, Haifa, Israel, North District. The company also has offices abroad.